KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Other financing activities: 2012-2024

Historic Other financing activities for Regeneron Pharmaceuticals (REGN) over the last 5 years, with Dec 2024 value amounting to -$33.4 million.

  • Regeneron Pharmaceuticals' Other financing activities was N/A to -$10.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$43.7 million, marking a year-over-year change of. This contributed to the annual value of -$33.4 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Regeneron Pharmaceuticals reported Other financing activities of -$33.4 million as of FY2024, which was down 108.24% from $405.3 million recorded in FY2015.
  • Regeneron Pharmaceuticals' 5-year Other financing activities high stood at -$33.4 million for FY2024, and its period low was -$33.4 million during FY2024.
  • Over the past 1 years, Regeneron Pharmaceuticals' median Other financing activities value was -$33.4 million (recorded in 2024), while the average stood at -$33.4 million.